Historic $25 million grant backs Garvan breast cancer research скачать в хорошем качестве

Historic $25 million grant backs Garvan breast cancer research

We are delighted to announce that Garvan has been awarded the inaugural Collaborative Research Accelerator (CRA) grant from the National Breast Cancer Foundation (NBCF) for its AllClear program, led by Garvan’s Associate Professor Christine Chaffer and Professor Peter Croucher. With funding of $25 million over five years, the CRA is one of the largest grants in Australia and the single largest research investment NBCF has made in its 30-year history. Collaborating research organisations will provide co-investment. We are truly honoured to receive this landmark investment, which will tackle one of breast cancer’s most urgent and unsolved challenges – stopping breast cancer relapse. It will focus on disseminated breast cancer cells – ‘seeds’ of relapse – that have spread to the bone and can lie dormant, capable of reawakening years or even decades later, to cause metastatic breast cancer. The AllClear program aims to: Identify and study the ‘seeds’ of relapse early Develop tools to predict who is most at risk of relapse Develop targeted therapies to eliminate these ‘seeds’ before they reawaken and cause metastatic breast cancer. AllClear is enabled by Garvan’s strategic collaboration with St Vincent’s Hospital Sydney and UNSW Sydney and is a collaboration of nearly 60 researchers across seven leading research institutes and organisations. This includes Breast Cancer Trials, the University of Sydney, the University of Newcastle, together with world-renowned international partners including Yale and Washington University, and 11 hospitals across NSW. Read more about this exciting news: https://www.garvan.org.au/news-resour...